methyl 6-(3-(4-chloro-3-(trifluoromethyl)phenyl)ureido)-4-oxo-1,4-dihydroquinoline-2-carboxylate

ID: ALA4206533

PubChem CID: 145978584

Max Phase: Preclinical

Molecular Formula: C19H13ClF3N3O4

Molecular Weight: 439.78

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COC(=O)c1cc(=O)c2cc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)ccc2[nH]1

Standard InChI:  InChI=1S/C19H13ClF3N3O4/c1-30-17(28)15-8-16(27)11-6-9(3-5-14(11)26-15)24-18(29)25-10-2-4-13(20)12(7-10)19(21,22)23/h2-8H,1H3,(H,26,27)(H2,24,25,29)

Standard InChI Key:  LORPJLDVRMGZNG-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 30 32  0  0  0  0  0  0  0  0999 V2000
   38.3323  -16.3066    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.3311  -17.1262    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.0392  -17.5351    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.0374  -15.8978    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.7460  -16.3030    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.7494  -17.1237    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.4578  -17.5288    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.1675  -17.1179    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.1641  -16.2972    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.4511  -15.8876    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   40.4600  -18.3460    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   41.8705  -15.8864    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.8680  -15.0693    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   42.5795  -16.2929    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   42.5820  -17.1100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.6231  -17.5342    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.9157  -17.1251    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.2077  -17.5331    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.9164  -16.3079    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   35.5003  -17.1239    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.5057  -16.3058    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.7992  -15.8967    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.0902  -16.3048    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.0921  -17.1262    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.7993  -17.5316    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.8002  -15.0795    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.5084  -14.6718    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   34.0930  -14.6700    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   34.7925  -14.2596    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   33.3822  -15.8966    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  5 10  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
  7 11  2  0
  9 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
  2 16  1  0
 16 17  1  0
 17 18  1  0
 17 19  2  0
 18 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 20  1  0
 22 26  1  0
 26 27  1  0
 26 28  1  0
 26 29  1  0
 23 30  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4206533

    ---

Associated Targets(Human)

KOPN-8 (317 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SUP-B15 (167 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SEM (217 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
UoC-B1 (90 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BJ (6930 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
THLE-2 (239 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 439.78Molecular Weight (Monoisotopic): 439.0547AlogP: 4.63#Rotatable Bonds: 3
Polar Surface Area: 100.29Molecular Species: NEUTRALHBA: 4HBD: 3
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 10.71CX Basic pKa: CX LogP: 4.58CX LogD: 4.58
Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.52Np Likeness Score: -1.27

References

1. Ling T, Lang W, Feng X, Das S, Maier J, Jeffries C, Shelat A, Rivas F..  (2018)  Novel vitexin-inspired scaffold against leukemia.,  146  [PMID:29407975] [10.1016/j.ejmech.2018.01.004]

Source